Raymond James analyst Frederic Bastien maintained a Hold rating on Stantec (STN – Research Report) today and set a price target of C$130.00. The company’s shares opened today at $79.77.
RBC Capital analyst Sabahat Khan maintained a Buy rating on Stantec (STN – Research Report) on January 27 and set a price target of C$128.00. The company’s shares closed yesterday at $78.51.
Stantec will design FIU's $212 million health sciences facility. FIU and Baptist Health South Florida are collaborating on this project. Construction is expected to be completed in 2028.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
